CBOE vs LUNG · P/E 24, rev $2.72B vs rev $43.3M
Cboe Global Markets Inc (CBOE) versus Pulmonx Corp (LUNG) — a side-by-side from cached financials, not a winner call.
Cboe Global Markets Inc (CBOE) is a financial data & stock exchanges company listed on US.
Pulmonx Corp (LUNG) is a medical devices company listed on US.
Latest reported CBOE revenue for 2026-06-30 was $2.72B. Net income was $738.8M. CBOE currently screens at market cap $29.50B and trailing P/E 24.1.
Latest reported LUNG revenue for 2026-06-30 was $43.3M. Net income was -$23.7M. LUNG currently screens at market cap $111.9M.
CBOE currently screens at market cap $29.50B and trailing P/E 24.1. LUNG currently screens at market cap $111.9M.
Not investment advice. Open the CBOE and LUNG stock pages for the full models.
Not investment advice.